Vitamin c boost: could high doses help chemo fight tough blood cancers?

NCT ID NCT03418038

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding high-dose vitamin C (ascorbic acid) to standard chemotherapy can help kill cancer cells better in people with certain blood cancers that have returned or not responded to treatment. It includes adults with relapsed or refractory lymphoma, clonal cytopenia of undetermined significance, and chronic myelomonocytic leukemia. The goal is to see if the combination improves response rates and is safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Mayo Clinic Health System-Eau Claire Clinic

    NOT_YET_RECRUITING

    Eau Claire, Wisconsin, 54701, United States

    Contact Email: •••••@•••••

  • Mayo Clinic Health System-Franciscan Healthcare

    ACTIVE_NOT_RECRUITING

    La Crosse, Wisconsin, 54601, United States

  • Mayo Clinic Health Systems-Mankato

    NOT_YET_RECRUITING

    Mankato, Minnesota, 56001, United States

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.